STAT+ Conversations: A conversation with Eli Lilly
Editor’s note: A livestream of the conversation will be embedded below at 1 p.m. ET.
Each week, STAT Plus subscribers enjoy exclusive interviews with STAT reporters and leaders in health care. This week, Matthew Herper, senior writer, medicine, at STAT will be joined by Daniel Skovronsky, senior vice president and chief scientific officer at Eli Lilly and Company. They’ll discuss the progress the company has made in developing an antibody drug against Covid-19, and how the treatment has been performing in early-stage testing.
Read Original Article: STAT+ Conversations: A conversation with Eli Lilly »
